368 related articles for article (PubMed ID: 34417822)
1. Longitudinal study of AMH variations in 122 Adolescents and Young Adults (AYA) and non-AYA lymphoma patients to evaluate the chemo-induced ovarian toxicity to further personalise fertility preservation counselling.
Decanter C; Delepine J; Behal H; Manier S; Bruno B; Barbatti M; Robin C; Labreuche J; Morschhauser F; Pigny P
Hum Reprod; 2021 Sep; 36(10):2743-2752. PubMed ID: 34417822
[TBL] [Abstract][Full Text] [Related]
2. Non-growing follicle density is increased following adriamycin, bleomycin, vinblastine and dacarbazine (ABVD) chemotherapy in the adult human ovary.
McLaughlin M; Kelsey TW; Wallace WH; Anderson RA; Telfer EE
Hum Reprod; 2017 Jan; 32(1):165-174. PubMed ID: 27923859
[TBL] [Abstract][Full Text] [Related]
3. Impact of ABVD chemotherapy on ovarian reserve after fertility preservation in reproductive-aged women with Hodgkin lymphoma.
Policiano C; Subirá J; Aguilar A; Monzó S; Iniesta I; Rubio Rubio JM
J Assist Reprod Genet; 2020 Jul; 37(7):1755-1761. PubMed ID: 32488563
[TBL] [Abstract][Full Text] [Related]
4. Determinants of ovarian function after response-adapted therapy in patients with advanced Hodgkin's lymphoma (RATHL): a secondary analysis of a randomised phase 3 trial.
Anderson RA; Remedios R; Kirkwood AA; Patrick P; Stevens L; Clifton-Hadley L; Roberts T; Hatton C; Kalakonda N; Milligan DW; McKay P; Rowntree C; Scott FM; Johnson PWM
Lancet Oncol; 2018 Oct; 19(10):1328-1337. PubMed ID: 30220622
[TBL] [Abstract][Full Text] [Related]
5. Spermatogenesis in Hodgkin's lymphoma patients: a retrospective study of semen quality before and after different chemotherapy regimens.
Paoli D; Rizzo F; Fiore G; Pallotti F; Pulsoni A; Annechini G; Lombardo F; Lenzi A; Gandini L
Hum Reprod; 2016 Feb; 31(2):263-72. PubMed ID: 26705149
[TBL] [Abstract][Full Text] [Related]
6. Gonadotrophin-releasing hormone agonists for fertility preservation: unraveling the enigma?
Hasky N; Uri-Belapolsky S; Goldberg K; Miller I; Grossman H; Stemmer SM; Ben-Aharon I; Shalgi R
Hum Reprod; 2015 May; 30(5):1089-101. PubMed ID: 25796551
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of ovarian reserve before and after chemotherapy.
Berjeb KK; Debbabi L; Braham M; Zemni Z; Chtourou S; Hannachi H; Hamdoun M; Ayadi M; Kacem K; Zhioua F; Fadhlaoui A; Bahri O; Chakroun N
J Gynecol Obstet Hum Reprod; 2021 May; 50(5):102035. PubMed ID: 33307239
[TBL] [Abstract][Full Text] [Related]
8. Anti-Müllerian hormone follow-up in young women treated by chemotherapy for lymphoma: preliminary results.
Decanter C; Morschhauser F; Pigny P; Lefebvre C; Gallo C; Dewailly D
Reprod Biomed Online; 2010 Feb; 20(2):280-5. PubMed ID: 20113967
[TBL] [Abstract][Full Text] [Related]
9. Intensified treatment of patients with early stage, unfavourable Hodgkin lymphoma: long-term follow-up of a randomised, international phase 3 trial of the German Hodgkin Study Group (GHSG HD14).
Gillessen S; Plütschow A; Fuchs M; Markova J; Greil R; Topp MS; Meissner J; Zijlstra JM; Eichenauer DA; Bröckelmann PJ; Diehl V; Borchmann P; Engert A; von Tresckow B
Lancet Haematol; 2021 Apr; 8(4):e278-e288. PubMed ID: 33770483
[TBL] [Abstract][Full Text] [Related]
10. Ovarian reserve after treatment with alkylating agents during childhood.
Thomas-Teinturier C; Allodji RS; Svetlova E; Frey MA; Oberlin O; Millischer AE; Epelboin S; Decanter C; Pacquement H; Tabone MD; Sudour-Bonnange H; Baruchel A; Lahlou N; De Vathaire F
Hum Reprod; 2015 Jun; 30(6):1437-46. PubMed ID: 25801499
[TBL] [Abstract][Full Text] [Related]
11. Cryopreservation of in vitro matured oocytes in addition to ovarian tissue freezing for fertility preservation in paediatric female cancer patients before and after cancer therapy.
Abir R; Ben-Aharon I; Garor R; Yaniv I; Ash S; Stemmer SM; Ben-Haroush A; Freud E; Kravarusic D; Sapir O; Fisch B
Hum Reprod; 2016 Apr; 31(4):750-62. PubMed ID: 26848188
[TBL] [Abstract][Full Text] [Related]
12. Serum anti-Müllerian hormone concentration and follicle density throughout reproductive life and in different diseases-implications in fertility preservation.
Liebenthron J; Reinsberg J; van der Ven K; Saenger N; Kruessel JS; von Wolff M
Hum Reprod; 2019 Dec; 34(12):2513-2522. PubMed ID: 31782794
[TBL] [Abstract][Full Text] [Related]
13. Fertility in young patients following treatment for Hodgkin's lymphoma: a single center survey.
Boltežar L; Pintarić K; Jezeršek Novaković B
J Assist Reprod Genet; 2016 Mar; 33(3):325-333. PubMed ID: 26678493
[TBL] [Abstract][Full Text] [Related]
14. Functional ovarian reserve in transgender men receiving testosterone therapy: evidence for preserved anti-Müllerian hormone and antral follicle count under prolonged treatment.
Yaish I; Tordjman K; Amir H; Malinger G; Salemnick Y; Shefer G; Serebro M; Azem F; Golani N; Sofer Y; Stern N; Greenman Y
Hum Reprod; 2021 Sep; 36(10):2753-2760. PubMed ID: 34411251
[TBL] [Abstract][Full Text] [Related]
15. Possible modification of BRSK1 on the risk of alkylating chemotherapy-related reduced ovarian function.
van der Kooi ALF; van Dijk M; Broer L; van den Berg MH; Laven JSE; van Leeuwen FE; Lambalk CB; Overbeek A; Loonen JJ; van der Pal HJ; Tissing WJ; Versluys B; Bresters D; Beerendonk CCM; Ronckers CR; van der Heiden-van der Loo M; Kaspers GL; de Vries ACH; Robison LL; Hudson MM; Chemaitilly W; Byrne J; Berger C; Clemens E; Dirksen U; Winther JF; Fosså SD; Grabow D; Haupt R; Kaiser M; Kepak T; Kruseova J; Modan-Moses D; Pluijm SMF; Spix C; Zolk O; Kaatsch P; Krijthe JH; Kremer LC; Yasui Y; Brooke RJ; Uitterlinden AG; van den Heuvel-Eibrink MM; van Dulmen-den Broeder E
Hum Reprod; 2021 Mar; 36(4):1120-1133. PubMed ID: 33582778
[TBL] [Abstract][Full Text] [Related]
16. Protective effect of goserelin on ovarian reserve during (neo)adjuvant chemotherapy in young breast cancer patients: a prospective cohort study in China.
Wang S; Pei L; Hu T; Jia M; Wang S
Hum Reprod; 2021 Mar; 36(4):976-986. PubMed ID: 33411897
[TBL] [Abstract][Full Text] [Related]
17. Impact of lymphoma treatments on spermatogenesis and sperm deoxyribonucleic acid: a multicenter prospective study from the CECOS network.
Bujan L; Walschaerts M; Brugnon F; Daudin M; Berthaut I; Auger J; Saias J; Szerman E; Moinard N; Rives N; Hennebicq S
Fertil Steril; 2014 Sep; 102(3):667-674.e3. PubMed ID: 25044088
[TBL] [Abstract][Full Text] [Related]
18. Serum metabolomics study of women with different annual decline rates of anti-Müllerian hormone: an untargeted gas chromatography-mass spectrometry-based study.
Moslehi N; Mirmiran P; Marzbani R; Rezadoost H; Mirzaie M; Azizi F; Tehrani FR
Hum Reprod; 2021 Feb; 36(3):721-733. PubMed ID: 33320198
[TBL] [Abstract][Full Text] [Related]
19. The addition of anti-Müllerian hormone in an algorithm for individualized hormone dosage did not improve the prediction of ovarian response-a randomized, controlled trial.
Magnusson Å; Nilsson L; Oleröd G; Thurin-Kjellberg A; Bergh C
Hum Reprod; 2017 Apr; 32(4):811-819. PubMed ID: 28175316
[TBL] [Abstract][Full Text] [Related]
20. Fertility and gonadal function in female survivors after treatment of early unfavorable Hodgkin lymphoma (HL) within the German Hodgkin Study Group HD14 trial.
Behringer K; Thielen I; Mueller H; Goergen H; Eibl AD; Rosenbrock J; Halbsguth T; Eichenauer DA; Fuchs M; Reiners KS; Renno JH; van der Ven K; Kuehr M; von Wolff M; Diehl V; Engert A; Borchmann P
Ann Oncol; 2012 Jul; 23(7):1818-25. PubMed ID: 22228451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]